Aspen Aerogels, Inc. (NYSE:ASPN) Receives Average Recommendation of "Moderate Buy" from Brokerages

Shares of Aspen Aerogels, Inc. (NYSE:ASPN - Get Free Report) have been assigned a consensus recommendation of "Moderate Buy" from the eleven brokerages that are presently covering the company, MarketBeat.com reports. Three investment analysts have rated the stock with a hold rating, seven have given a buy rating and one has issued a strong buy rating on the company. The average twelve-month price objective among analysts that have issued a report on the stock in the last year is $18.44.

Several research analysts have recently commented on ASPN shares. Oppenheimer lowered Aspen Aerogels from an "outperform" rating to a "market perform" rating in a research report on Thursday, May 8th. Barclays reissued an "equal weight" rating and issued a $7.00 price target (down from $13.00) on shares of Aspen Aerogels in a research report on Thursday, May 29th.

Aspen Aerogels Trading Up 5.3%

Shares of Aspen Aerogels stock traded up $0.34 on Monday, reaching $6.68. The company had a trading volume of 1,094,241 shares, compared to its average volume of 2,029,615. The firm has a market cap of $548.08 million, a price-to-earnings ratio of -1.91 and a beta of 2.65. The company has a debt-to-equity ratio of 0.40, a current ratio of 4.22 and a quick ratio of 3.53. The firm's 50-day moving average price is $6.17 and its two-hundred day moving average price is $7.64. Aspen Aerogels has a 1 year low of $4.16 and a 1 year high of $33.15.

Aspen Aerogels (NYSE:ASPN - Get Free Report) last posted its quarterly earnings data on Thursday, May 8th. The construction company reported ($0.06) earnings per share (EPS) for the quarter, beating analysts' consensus estimates of ($0.07) by $0.01. Aspen Aerogels had a positive return on equity of 6.69% and a negative net margin of 65.47%. The company had revenue of $78.72 million during the quarter, compared to analysts' expectations of $82.75 million. During the same quarter in the previous year, the business earned ($0.02) EPS. Aspen Aerogels's revenue was down 16.7% compared to the same quarter last year. As a group, research analysts predict that Aspen Aerogels will post 0.17 earnings per share for the current fiscal year.

Insider Buying and Selling at Aspen Aerogels

In related news, CEO Donald R. Young purchased 20,000 shares of the company's stock in a transaction that occurred on Monday, May 12th. The shares were purchased at an average price of $5.35 per share, for a total transaction of $107,000.00. Following the transaction, the chief executive officer directly owned 550,856 shares of the company's stock, valued at approximately $2,947,079.60. The trade was a 3.77% increase in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Insiders own 4.30% of the company's stock.

Hedge Funds Weigh In On Aspen Aerogels

Several institutional investors and hedge funds have recently added to or reduced their stakes in the business. Invesco Ltd. increased its position in Aspen Aerogels by 3.5% during the 4th quarter. Invesco Ltd. now owns 50,871 shares of the construction company's stock worth $604,000 after purchasing an additional 1,724 shares during the period. Alps Advisors Inc. increased its position in Aspen Aerogels by 1.7% during the 1st quarter. Alps Advisors Inc. now owns 126,326 shares of the construction company's stock worth $807,000 after purchasing an additional 2,093 shares during the period. MetLife Investment Management LLC grew its holdings in shares of Aspen Aerogels by 6.3% in the 4th quarter. MetLife Investment Management LLC now owns 35,782 shares of the construction company's stock worth $425,000 after acquiring an additional 2,118 shares during the period. Swiss National Bank grew its holdings in shares of Aspen Aerogels by 1.9% in the 4th quarter. Swiss National Bank now owns 128,800 shares of the construction company's stock worth $1,530,000 after acquiring an additional 2,400 shares during the period. Finally, Journey Strategic Wealth LLC grew its holdings in shares of Aspen Aerogels by 17.3% in the 1st quarter. Journey Strategic Wealth LLC now owns 17,596 shares of the construction company's stock worth $112,000 after acquiring an additional 2,596 shares during the period. Institutional investors and hedge funds own 97.64% of the company's stock.

About Aspen Aerogels

Aspen Aerogels, Inc designs, develops, manufactures, and sells aerogel insulation products primarily for use in the energy infrastructure and sustainable insulation materials markets in the United States, Asia, Canada, Europe, and Latin America. It operates in two segments, Energy Industrial and Thermal Barrier.